Showing results (31-40 of 138) with videos related to
Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modelingMeir Wetzler, Justin C Earp, Michael T Brady, et al.The Annals of Pharmacotherapy|July 5, 2003
Simvastatin-fluconazole causing rhabdomyolysisAasma Shaukat, Mustafa Benekli, Georgirene D Vladutiu, et al.Cancer|January 27, 2010
Adult acute lymphoblastic leukemia: concepts and strategiesStefan Faderl, Susan O'Brien, Ching-Hon Pui, et al.Expert Opinion on Biological Therapy|May 20, 2015
Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignanciesBritny Rogala, Craig W Freyer, Evelena P Ontiveros, et al.Blood Reviews|January 24, 2015
Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapyLin Mei, Evelena P Ontiveros, Elizabeth A Griffiths, et al.European Journal of Cancer (Oxford, England : 1990)|December 25, 2021
Impact of abiraterone acetate plus prednisone in patients with castration-sensitive prostate cancer and visceral metastases over four years of follow-up: A post-hoc exploratory analysis of the LATITUDE studyGiulia Baciarello, Mustafa Özgüroğlu, Suneel Mundle, et al.Leukemia Research Reports|September 3, 2014
High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failureMorgan B Smith, Elizabeth A Griffiths, James E Thompson, et al.American Journal of Clinical Pathology|April 15, 2004
Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patientsRina Kansal, George Deeb, Maurice Barcos, et al.Leukemia Research|August 14, 2012
Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modelingKaren E Thudium, Sampa Ghoshal, Gerald J Fetterly, et al.Expert Opinion on Orphan Drugs|August 8, 2019
Bosutinib for the Treatment of Philadelphia Chromosome-Positive LeukemiasCristina Varallo-Rodriguez, Craig W Freyer, Evelena P Ontiveros, et al.Pageof 14